High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Clinical trial NCT00002818 · COMPLETED

Trial details

NCT number: NCT00002818
Sponsor: Virginia Commonwealth University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm

Start date: 1995-02-01
Primary completion: 2001-02-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.